It is shocking that a commissioner would choose to resign rather than watch an agency's bipartisan tradition crumble in front of her eyes.
It requires the FTC to study pharmaceutical intermediaries and issue a report and recommendations to Congress within one...
FMI thanks Chairwoman Cantwell and Sen. Grassley for championing the PBM Transparency Act.
PBMs are blocking a cheaper product.
The Cantwell-Grassley PBM transparency bill directs the FTC to end well-known and documented PBM practices that drive up...
I hope this committee will have the same success voting this bill out.
I believe, like Senator Cruz just said, that the consumer ought to be the point of everything that we are trying to acco...
PBMs will claim they pass on savings to consumers or through lowering premiums, but their spread pricing and clawback ta...
The Cantwell-Grassley PBM Transparency Act directs the FTC to end well-known and documented PBM practices that drive up ...
I worked at the FTC, and I can tell you that with the Agency's overreach and activism, which will no doubt be difficult ...
I'll flag one other concern for the bill. It would pre-judge the results of the FTC's current study on the economic effe...